Oresun Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 29-05-2024
- Paid Up Capital ₹ 0.50 M
as on 29-05-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 178.55%
(FY 2022)
- Profit 54.55%
(FY 2022)
- Ebitda 52.55%
(FY 2022)
- Net Worth -538.86%
(FY 2022)
- Total Assets 55.33%
(FY 2022)
About Oresun Laboratories
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Priya Pallavi, Rahul Prakash, and Dinesh Sharma serve as directors at the Company.
- CIN/LLPIN
U74999PB2019PTC054900
- Company No.
042354
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Mohali, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Oresun Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priya Pallavi  | Director | 08-May-2023 | Current |
| Rahul Prakash | Director | 25-Jan-2019 | Current |
| Dinesh Sharma | Director | 25-Jan-2019 | Current |
Financial Performance of Oresun Laboratories.
Oresun Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 178.55% increase. The company also saw a substantial improvement in profitability, with a 54.55% increase in profit. The company's net worth observed a substantial decline by a decrease of 538.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oresun Laboratories?
Unlock access to Oresun Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sun Packmet Private LimitedActive 19 years 1 monthRahul Prakash and Dinesh Sharma are mutual person
Suncare Biogenetics Private LimitedActive 2 years 10 monthsRahul Prakash and Dinesh Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oresun Laboratories?
Unlock and access historical data on people associated with Oresun Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oresun Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oresun Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
